Factor VIIa, Factor VIII, Factor IX, Factor xIII

Brand Name(s):

Indication:Haemorrhage in patients with haemophilia A or B with antibodies to factors VIII or IX, acquired haemophilia, factor VII deficiency, or Glanzmann’s thrombasthenia

Rationale:1,2

Considered:Dec-07

Review Date:Dec-22